Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes

被引:326
作者
Greenbaum, Jason [1 ]
Sidney, John [1 ]
Chung, Jolan [1 ]
Brander, Christian [2 ]
Peters, Bjoern [1 ]
Sette, Alessandro [1 ]
机构
[1] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA
[2] Hosp Badalona Germans Trias & Pujol, AIDS Res Inst, Fdn IrsiCaixa HIVACAT, Barcelona 08916, Catalonia, Spain
基金
美国国家卫生研究院;
关键词
MHC; HLA class I; HLA class II; Peptide binding; T cell epitopes; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-BINDING REPERTOIRES; WORLDWIDE HUMAN-POPULATION; T-CELL EPITOPES; 3-DIMENSIONAL STRUCTURE; MHC SUPERTYPES; SPECIFICITY; MOTIFS; ALLELES; PROTEIN;
D O I
10.1007/s00251-011-0513-0
中图分类号
Q3 [遗传学];
学科分类号
071007 [遗传学];
摘要
Previous studies have attempted to define human leukocyte antigen (HLA) class II supertypes, analogous to the case for class I, on the basis of shared peptide-binding motifs or structure. In the present study, we determined the binding capacity of a large panel of non-redundant peptides for a set of 27 common HLA DR, DQ, and DP molecules. The measured binding data were then used to define class II supertypes on the basis of shared binding repertoires. Seven different supertypes (main DR, DR4, DRB3, main DQ, DQ7, main DP, and DP2) were defined. The molecules associated with the respective supertypes fell largely along lines defined by MHC locus and reflect, in broad terms, commonalities in reported peptide-binding motifs. Repertoire overlaps between molecules within the same class II supertype were found to be similar in magnitude to what has been observed for HLA class I supertypes. Surprisingly, however, the degree to which repertoires between molecules in the different class II supertypes also overlapped was found to be five to tenfold higher than repertoire overlaps noted between molecules in different class I supertypes. These results highlight a high degree of repertoire overlap amongst all HLA class II molecules, perhaps reflecting binding in multiple registers, and more pronounced dependence on backbone interactions rather than peptide anchor residues. This fundamental difference between HLA class I and class II would not have been predicted on the basis of analysis of either binding motifs or the sequence/predicted structures of the HLA molecules.
引用
收藏
页码:325 / 335
页数:11
相关论文
共 60 条
[1]
DEVELOPMENT OF HIGH POTENCY UNIVERSAL DR-RESTRICTED HELPER EPITOPES BY MODIFICATION OF HIGH-AFFINITY DR-BLOCKING PEPTIDES [J].
ALEXANDER, J ;
SIDNEY, J ;
SOUTHWOOD, S ;
RUPPERT, J ;
OSEROFF, C ;
MAEWAL, A ;
SNOKE, K ;
SERRA, HM ;
KUBO, RT ;
SETTE, A ;
GREY, HM .
IMMUNITY, 1994, 1 (09) :751-761
[2]
Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8+T-cell responses [J].
Axelsson-Robertson, Rebecca ;
Weichold, Frank ;
Sizemore, Donata ;
Wulf, Markus ;
Skeiky, Yasir A. W. ;
Sadoff, Jerry ;
Maeurer, Markus J. .
IMMUNOLOGY, 2010, 129 (04) :496-505
[3]
ALLELIC VARIATION IN THE DR SUBREGION OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX [J].
BELL, JI ;
DENNEY, D ;
FOSTER, L ;
BELT, T ;
TODD, JA ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (17) :6234-6238
[4]
Detailed analysis of the effects of Glu/Lys β69 human leukocyte antigen-DP polymorphism on peptide-binding specificity [J].
Berretta, F ;
Butler, RH ;
Diaz, G ;
Sanarico, N ;
Arroyo, J ;
Fraziano, M ;
Aichinger, G ;
Wucherpfennig, KW ;
Colizzi, V ;
Saltini, C ;
Amicosante, M .
TISSUE ANTIGENS, 2003, 62 (06) :459-471
[5]
BOITEL B, 1995, J IMMUNOL, V154, P3245
[6]
3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[7]
A geometric study of the amino acid sequence of class I HLA molecules [J].
Cano, P ;
Bo, F ;
Stass, S .
IMMUNOGENETICS, 1998, 48 (05) :324-334
[8]
Castelli FA, 2002, J IMMUNOL, V169, P6928, DOI 10.4049/jimmunol.169.12.6928
[9]
A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities [J].
Chelvanayagam, G .
IMMUNOGENETICS, 1996, 45 (01) :15-26
[10]
A roadmap for HLA-DR peptide binding specificities [J].
Chelvanayagam, G .
HUMAN IMMUNOLOGY, 1997, 58 (02) :61-69